Beijing Scitop Price To Sales vs. Revenue

300858 Stock   16.47  0.25  1.54%   
Considering Beijing Scitop's profitability and operating efficiency indicators, Beijing Scitop Bio may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in January. Profitability indicators assess Beijing Scitop's ability to earn profits and add value for shareholders.
For Beijing Scitop profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Beijing Scitop to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Beijing Scitop Bio utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Beijing Scitop's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Beijing Scitop Bio over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
Please note, there is a significant difference between Beijing Scitop's value and its price as these two are different measures arrived at by different means. Investors typically determine if Beijing Scitop is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Beijing Scitop's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Beijing Scitop Bio Revenue vs. Price To Sales Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Beijing Scitop's current stock value. Our valuation model uses many indicators to compare Beijing Scitop value to that of its competitors to determine the firm's financial worth.
Beijing Scitop Bio is number one stock in price to sales category among its peers. It also is the top company in revenue category among its peers totaling about  20,755,747  of Revenue per Price To Sales. At present, Beijing Scitop's Total Revenue is projected to increase significantly based on the last few years of reporting. Comparative valuation analysis is a catch-all model that can be used if you cannot value Beijing Scitop by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Beijing Scitop's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Beijing Revenue vs. Price To Sales

Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.

Beijing Scitop

P/S

 = 

MV Per Share

Revenue Per Share

 = 
14.42 X
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.

Beijing Scitop

Revenue

 = 

Money Received

-

Discounts and Returns

 = 
299.24 M
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.

Beijing Revenue vs Competition

Beijing Scitop Bio is the top company in revenue category among its peers. Market size based on revenue of Health Care industry is presently estimated at about 94.25 Billion. Beijing Scitop adds roughly 299.24 Million in revenue claiming only tiny portion of equities under Health Care industry.

Beijing Scitop Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Beijing Scitop, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Beijing Scitop will eventually generate negative long term returns. The profitability progress is the general direction of Beijing Scitop's change in net profit over the period of time. It can combine multiple indicators of Beijing Scitop, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Net Interest Income23.5 M24.6 M
Operating Income73.5 M99.4 M
Net Income From Continuing Ops93.5 M93.1 M
Income Before Tax102 M109.3 M
Net Income Applicable To Common Shares126.4 M91.8 M
Net Income93.5 M93.2 M
Income Tax Expense18.1 M17.1 M
Interest Income24 M25.2 M
Change To Netincome-9.2 M-8.7 M

Beijing Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Beijing Scitop. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Beijing Scitop position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Beijing Scitop's important profitability drivers and their relationship over time.

Use Beijing Scitop in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Beijing Scitop position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Beijing Scitop will appreciate offsetting losses from the drop in the long position's value.

Beijing Scitop Pair Trading

Beijing Scitop Bio Pair Trading Analysis

The ability to find closely correlated positions to Beijing Scitop could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Beijing Scitop when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Beijing Scitop - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Beijing Scitop Bio to buy it.
The correlation of Beijing Scitop is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Beijing Scitop moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Beijing Scitop Bio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Beijing Scitop can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Beijing Scitop position

In addition to having Beijing Scitop in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Blockchain Thematic Idea Now

Blockchain
Blockchain Theme
Companies across muliple sectors and different technology products and services that are engaged in some capacity with blockchain technolgoy or evolution of cryptocurrency. The Blockchain theme has 42 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Blockchain Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Beijing Stock

To fully project Beijing Scitop's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Beijing Scitop Bio at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Beijing Scitop's income statement, its balance sheet, and the statement of cash flows.
Potential Beijing Scitop investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Beijing Scitop investors may work on each financial statement separately, they are all related. The changes in Beijing Scitop's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Beijing Scitop's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.